lexatumumab
mapatumumab
conatumumab
panitumumab
oleclumab
tenatumomab
patritumab
tigatuzumab
sibrotuzumab
acrixolimab
inotuzumab
duligotuzumab
dalotuzumab
matuzumab
lintuzumab
figitumumab
drozitumab
naptumomab estafenatox
inotuzumab ozogamicin
onartuzumab
pamrevlumab
iratumumab
nofetumomab
dacetuzumab
samalizumab
agonistic monoclonal antibody
adecatumumab
avelumab
pritumumab
teprotumumab
brentuximab
carlumab
lucatumumab
durvalumab
cergutuzumab
apolizumab
bivatuzumab
alacizumab
catumaxomab
oportuzumab monatox
ertumaxomab
sonepcizumab
tucotuzumab
elotuzumab
teplizumab
dorlixizumab
ocrelizumab
cixutumumab
ramucirumab
volociximab